Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study

By Hiwatashi Nobuo   Suzuki Yasuo   Mitsuyama Keiichi   Munakata Akihiro   Hibi Toshifumi  

Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 46-56

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis

By Oxelmark Lena   Hillerås Pernilla   Dignass Axel   Mössner Joachim   Schreiber Stefan   Kruis Wolfgang   Löfberg Robert  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 3, 2007-01 ,pp. : 406-407

Informa Healthcare

Access to resources Recommend Favorite

Oral or Topical 5-ASA in Ulcerative Colitis

By  

Digestive Diseases, Vol. 34, Iss. 1-2, 2016-03 ,pp. : 122-124

Karger

Access to resources Recommend Favorite

Oral Prednisolone Metasulphobenzoate in the Treatment of Active Ulcerative Colitis

By Cameron E. A. B.   Binnie J. A. H.   Balan K.   Skerratt S. A.   Swift A.   Solanki C.   Middleton S. J.  

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 5, 2003-01 ,pp. : 535-537

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up

By Ohkusa Toshifumi   Nomura Tetsuya   Terai Takeshi   Miwa Hiroto   Kobayashi Osamu   Hojo Mariko   Takei Yoshiyuki   Ogihara Tatsuo   Hirai Shu   Okayasu Isao   Sato Nobuhiro  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 11, 2005-11 ,pp. : 1334-1342

Informa Healthcare

Access to resources Recommend Favorite